GOLDMAN SACHS GROUP INC - NIVALIS THERAPEUTICS INC ownership

NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 63 filers reported holding NIVALIS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NIVALIS THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$94,000
-85.0%
42,130
-45.3%
0.00%
Q3 2016$626,000
+396.8%
77,023
+181.9%
0.00%
Q2 2016$126,000
+46.5%
27,324
+32.2%
0.00%
Q1 2016$86,000
-97.0%
20,667
-94.4%
0.00%
-100.0%
Q4 2015$2,863,000
-40.8%
369,858
-0.9%
0.00%
-50.0%
Q3 2015$4,840,000
-18.6%
373,170
-4.9%
0.00%0.0%
Q2 2015$5,947,000392,5140.00%
Other shareholders
NIVALIS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,732,412$48,409,0001.87%
RA Capital Management 612,863$7,949,0001.14%
TIGER MANAGEMENT L.L.C. 650,915$8,442,0001.13%
Opaleye Management Inc. 175,200$2,272,0001.12%
Rock Springs Capital Management LP 489,000$6,342,0000.52%
WALL STREET ASSOCIATES 170,400$2,210,0000.42%
SPHERA FUNDS MANAGEMENT LTD. 201,720$2,616,0000.33%
KINGDON CAPITAL MANAGEMENT, L.L.C. 418,903$5,433,0000.26%
SABBY MANAGEMENT, LLC 384,734$4,990,0000.21%
DAFNA Capital Management LLC 15,000$195,0000.19%
View complete list of NIVALIS THERAPEUTICS INC shareholders